Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cecilia Barbara
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-Line Cetuximab and Irinotecan
JAMA Oncology
Cancer Research
Oncology
DPYD*6 Plays an Important Role in Fluoropyrimidine Toxicity in Addition to DPYD*2A and C.2846A>T: A Comprehensive Analysis in 1254 Patients
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- And PIK3CA- Wild-Type Metastatic Colorectal Cancer: The AGITG Randomised Phase II ICECREAM Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Rechallenge and Maintenance Therapy Using Cetuximab and Chemotherapy Administered to a Patient With Metastatic Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
RAS and BRAF in Metastatic Colorectal Cancer Management
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada
International Journal of Cancer
Cancer Research
Oncology
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients With Kras Wild-Type Tumours in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
